Literature DB >> 15845861

Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1.

Cheng Chang1, K Sandy Pang, Peter W Swaan, Sean Ekins.   

Abstract

The organic anion transporting polypeptides OATPs are key membrane transporters for which crystal structures are not currently available. They transport a diverse array of xenobiotics and are expressed at the interface of hepatocytes, renal tubular cells, enterocytes, and the choroid plexus. To aid the understanding of the key molecular features for substrate-transporter interactions, pharmacophore models were produced for the two OATPs that have been most extensively studied, namely rat Oatp1a1 and human OATP1B1. Literature data from Chinese hamster ovary, HeLa, human embryonic kidney 293 cells, and Xenopus laevis oocytes were used to construct pharmacophores for each individual transporter which were later merged to show similarities across cell lines for the same transporter. Additionally, meta-pharmacophores were generated from the combined datasets of each cell system used with the same transporter. The pharmacophores for each transporter consisted of hydrogen bond acceptor and hydrophobic features. There was good agreement between the merged and meta-pharmacophores containing two hydrogen bond acceptors and two or three hydrophobic features for Oatp1a1 and OATP1B1. External test sets were used to validate the individual pharmacophores. The meta-pharmacophores were also used to make predictions for molecules not included in the models and provided new molecular insight into the key features for these OATP transporters. This approach can be extended to other transporters for which limited data are available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845861     DOI: 10.1124/jpet.104.082370

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

4.  Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

Authors:  Brian C Ferslew; Kathleen Köck; Arlene S Bridges; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2014-06-23       Impact factor: 3.922

5.  In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.

Authors:  Maria Karlgren; Gustav Ahlin; Christel A S Bergström; Richard Svensson; Johan Palm; Per Artursson
Journal:  Pharm Res       Date:  2011-08-23       Impact factor: 4.200

6.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

7.  Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition.

Authors:  S Ekins; J E Polli; P W Swaan; S H Wright
Journal:  Clin Pharmacol Ther       Date:  2012-09-26       Impact factor: 6.875

Review 8.  Impact of OATP transporters on pharmacokinetics.

Authors:  A Kalliokoski; M Niemi
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.

Authors:  Yu Fukuda; Kazumasa Takenaka; Alex Sparreboom; Satish B Cheepala; Chung-Pu Wu; Sean Ekins; Suresh V Ambudkar; John D Schuetz
Journal:  Mol Pharmacol       Date:  2013-06-17       Impact factor: 4.436

10.  Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17beta-glucuronide transport.

Authors:  Chunshan Gui; Brett Wahlgren; Gerald H Lushington; Bruno Hagenbuch
Journal:  Pharmacol Res       Date:  2009-03-17       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.